title: Tenecteplase in prosthetic mitral valve thrombosis.
abstract: In the few reported cases of prosthetic mitral valve thrombosis, where surgical intervention was considered as high risk, fibrinolytic therapy had proved life saving. The authors present clinical, laboratory, and imaging data from such a patient, with prosthetic mitral valve thrombosis and its successful management with tenecteplase. The use of tenecteplase as a viable fibrinolytic agent for the first time was justified, due to the lack of immunogenicity concerns compared to streptokinase.
authors: Cardiac Science Department, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
authors: Masood
authors: M
authors: Ayyub Ghori
authors: Sherif
authors: S
authors: Bakir
authors: Samer
authors: S
authors: Ellahham
authors: Adnan
authors: A
authors: Al Nassir
authors: Abdulmajeed
authors: A
authors: Al Zubaidi
authors: Norbert
authors: N
authors: Augustin
authors: Moataz Ayman
authors: MA
authors: Abdelaziz
authors: Nicolas Patrick
authors: NP
authors: Turrin
authors: Wael Abdulrahman
authors: WA
authors: Al Mahmeed
keywords: Prosthetic valve; Tenecteplase; Thrombosis
references: Int J Cardiol. 2001 Apr;78(2):197-8
references: 11398769
references: Am J Cardiol. 2000 Jan 1;85(1):58-64
references: 11078238
references: J Am Coll Cardiol. 1998 Nov;32(5):1410-7
references: 9809956
references: Circulation. 2008 Oct 7;118(15):e523-661
references: 18820172
references: Internist (Berl). 2008 Jul;49(7):868-72
references: 18512035
references: J Thromb Thrombolysis. 2006 Apr;21(2):185-90
references: 16622616